EG19826A - Indole - and benzimidazole - substituted imidazole and benzimidazole derivatives - Google Patents

Indole - and benzimidazole - substituted imidazole and benzimidazole derivatives

Info

Publication number
EG19826A
EG19826A EG66391A EG66391A EG19826A EG 19826 A EG19826 A EG 19826A EG 66391 A EG66391 A EG 66391A EG 66391 A EG66391 A EG 66391A EG 19826 A EG19826 A EG 19826A
Authority
EG
Egypt
Prior art keywords
benzimidazole
indole
substituted imidazole
derivatives
benzimidazole derivatives
Prior art date
Application number
EG66391A
Other languages
English (en)
Inventor
Michael Anthony Poss
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of EG19826A publication Critical patent/EG19826A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG66391A 1990-10-31 1991-10-30 Indole - and benzimidazole - substituted imidazole and benzimidazole derivatives EG19826A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60663190A 1990-10-31 1990-10-31

Publications (1)

Publication Number Publication Date
EG19826A true EG19826A (en) 1996-03-31

Family

ID=24428787

Family Applications (1)

Application Number Title Priority Date Filing Date
EG66391A EG19826A (en) 1990-10-31 1991-10-30 Indole - and benzimidazole - substituted imidazole and benzimidazole derivatives

Country Status (23)

Country Link
EP (1) EP0488532A1 (pl)
JP (1) JPH0592969A (pl)
KR (1) KR920008032A (pl)
CN (1) CN1061224A (pl)
AU (1) AU650294B2 (pl)
CA (1) CA2054594A1 (pl)
CS (1) CS330591A3 (pl)
EG (1) EG19826A (pl)
FI (1) FI915148A7 (pl)
HU (1) HU214575B (pl)
IE (1) IE913785A1 (pl)
IL (1) IL99917A0 (pl)
MX (1) MX9101873A (pl)
MY (1) MY108611A (pl)
NO (1) NO180749C (pl)
NZ (1) NZ240383A (pl)
PH (1) PH31175A (pl)
PL (1) PL168902B1 (pl)
PT (1) PT99404A (pl)
RO (1) RO109735B1 (pl)
RU (1) RU2111208C1 (pl)
YU (1) YU173791A (pl)
ZA (1) ZA918688B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
GB9113626D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic compounds
GB9113628D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic derivatives
CA2109932A1 (en) * 1992-03-25 1993-09-30 Yoshihisa Inoue Isoindazole compound
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
US5538973A (en) * 1992-03-27 1996-07-23 Kyoto Pharmaceutical Industries, Ltd. Imidazole derivative, pharmaceutical use thereof, and intermediate therefor
CA2109931A1 (en) * 1992-03-27 1993-10-14 Hiroshi Matsui Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
MXPA06014535A (es) 2004-06-18 2007-06-05 Biolipox Ab Indoles utiles en el tratamiento de la inflamacion.
EP1771169A1 (en) 2004-07-14 2007-04-11 PTC Therapeutics, Inc. Methods for treating hepatitis c
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (ja) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス,インコーポレーテッド C型肝炎を治療するためのチエノピリジン
BRPI0519774A2 (pt) 2005-01-19 2009-02-10 Biolipox Ab composto ou um sal farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, uso de um composto ou um sal farmaceuticamente aceitÁvel do mesmo, mÉtodo de tratamento de uma doenÇa em que inibiÇço da atividade de um membro da famÍlia mapeg É desejada e/ou necessÁria, produto combinado, e, processo para a preparaÇço de um composto
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (en) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103965167A (zh) * 2013-01-29 2014-08-06 通化济达医药有限公司 咪唑羧酸衍生物
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
CN106397414A (zh) * 2015-08-14 2017-02-15 陈志龙 杂螺环酮吲哚衍生物的一种制备方法
JP2024506858A (ja) 2021-02-02 2024-02-15 リミナル・バイオサイエンシーズ・リミテッド Gpr84アンタゴニストおよびその使用
CN113999204B (zh) * 2021-11-08 2023-09-05 常州大学 一种非手性咪唑型离子化合物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US4826862A (en) * 1988-02-12 1989-05-02 Janssen Pharmaceutica, N.V. Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8820231D0 (en) * 1988-08-25 1988-09-28 Fujisawa Pharmaceutical Co New benzazole compounds processes for preparation thereof & pharmaceutical composition comprising same
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung

Also Published As

Publication number Publication date
IL99917A0 (en) 1992-08-18
MX9101873A (es) 1992-06-05
EP0488532A1 (en) 1992-06-03
HU214575B (hu) 1998-04-28
CA2054594A1 (en) 1992-05-01
NO180749B (no) 1997-03-03
RU2111208C1 (ru) 1998-05-20
IE913785A1 (en) 1992-05-22
MY108611A (en) 1996-10-31
NO180749C (no) 1997-06-11
YU173791A (sh) 1994-01-20
HUT59677A (en) 1992-06-29
NZ240383A (en) 1994-12-22
CN1061224A (zh) 1992-05-20
PL292249A1 (en) 1992-07-13
RO109735B1 (ro) 1995-05-30
FI915148A7 (fi) 1992-05-01
ZA918688B (en) 1992-08-26
PL168902B1 (pl) 1996-05-31
HU913418D0 (en) 1992-01-28
AU650294B2 (en) 1994-06-16
CS330591A3 (en) 1992-06-17
NO914263D0 (no) 1991-10-30
NO914263L (no) 1992-05-04
AU8691091A (en) 1992-05-07
PH31175A (en) 1998-03-20
PT99404A (pt) 1992-09-30
JPH0592969A (ja) 1993-04-16
FI915148A0 (fi) 1991-10-31
KR920008032A (ko) 1992-05-27

Similar Documents

Publication Publication Date Title
EG19826A (en) Indole - and benzimidazole - substituted imidazole and benzimidazole derivatives
EP0525129A4 (en) Substituted benzimidazoles
GB2244487B (en) Azole derivatives
EG19910A (en) Fungicidal 2-imidazolin-5-one and 2-imidazoline-5-thione derivatives
ZA912178B (en) Hydantoin derivatives
ZA909603B (en) Fungicidal imidazole diphenylaliphaticboranes and derivatives thereof
GB9121776D0 (en) Benzimidazole derivatives and process for preparation thereof
ZA932550B (en) Fungicidal triazole and imidazole derivatives
ZA93144B (en) Substituted benzimidazole derivatives
GB9020128D0 (en) Imidazoline derivatives
HU9204001D0 (en) New imidazole derivatives
ZA925283B (en) Benzimidazoles
ZA894414B (en) Imidazole derivatives
IE901433L (en) Imidazole derivatives
IE900195L (en) Imidazole derivatives
SG67903A1 (en) Benzimidazole derivatives their production and use
NZ234744A (en) Substituted imidazole derivatives and pharmaceutical compositions
HU9300540D0 (en) Sulfonyl-benzyl substituted imidazole derivatives
GB9027892D0 (en) Imidazoles
IE901923L (en) Heterocycle-fused imidazoles
IE900746L (en) Benzimidazoles and azabenzimidazoles
ZA914094B (en) Azole derivatives
IL112684A0 (en) Azole derivatives
ZA911440B (en) Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
IE900348L (en) Benzimidazole derivatives.